Monoclonal antibodies for preventing respiratory syncytial virus infection

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2007, Pages

  Lozano, Juan Manuel ^a   Escovar, C ^b   Vasquez V ^b  

^a PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

ARTIFICIAL VENTILATION; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; HIGH RISK INFANT; HOSPITAL ADMISSION; HUMAN; INFECTION PREVENTION; INTENSIVE CARE; MORTALITY; NONHUMAN; RANDOMIZATION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; RISK ASSESSMENT; TREATMENT RESPONSE; VIRUS INFECTION;

EID: 44949228398     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006602     Document Type: Review

References (18)

1. Boyce 2000 Boyce TG, Mellen BG, Mitchel EF Jr, Wright PF, Griffin MR. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid. Journal of Pediatrics 2000;137:865-70.
2. Fleming 2005 Fleming DM, Pannell RS, Cross KW. Mortality in children from influenza and respiratory syncytial virus. Journal of Epidemiology and Community Health 2005;59:586-90.
3. Glezen 1986 Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. American Journal of Diseases of Children 1986;140:543-6.
4. Greenough 2002 Greenough A. Respiratory syncytial virus infection: clinical features, management, and prophylaxis. Current Opinion in Pulmonary Medicine 2002;8:214.
5. Haynes 2005 Haynes RB, McKibbon KA, Wilczynski NL, Walter SD, Werre SR, Hedges Team. Optimal search strategies for retrieving scientifically strong studies of treatment from Medline: analytical survey. BMJ 2005;330:1179.
6. Higgins 2002 Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21:1539-58.
7. Higgins 2005 Higgins JPT, Green S, editors. Assessment of study quality. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]; Section 6. http://www.cochrane.org/resources/handbook/hbook. htm (accessed 4 January 2007) 2005.
8. Holman 2004 Holman RC, Curns AT, Cheek JE, Bresee JS, Singleton RJ, Carver K, et al.Respiratory syncytial virus hospitalizations among American Indian and Alaska Native infants and the general United States infant population. Pediatrics 2004;114:437-44.
9. Mansbach 2005 Mansbach JM, Emond JA, Camargo CA Jr. Bronchiolitis in US emergency departments 1992 to 2000: epidemiology and practice variation. Pediatric Emergency Care 2005;21:242-7.
10. Moher 1998 Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al.Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352:609-13.
11. Purcell 2004 Purcell K, Fergie J. Driscoll Children's Hospital respiratory syncytial virus database: risk factors, treatment and hospital course in 3308 infants and young children, 1991 to 2002. Pediatric Infectious Disease Journal 2004;23:418-23.
12. Sanchez 2002 Sanchez PJ. Immunoprophylaxis for respiratory syncytial virus. Pediatric Infectious Disease Journal 2002;21:473-8.
13. Schulz 1995 Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of the American Medical Association 1995;273:408-12.
14. Shay 2001 Shay DK, Holman RC, Roosevelt GE, Clarke MJ, Anderson LJ. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. Journal of Infectious Diseases 2001;183:16-22.
15. Simoes 1999 Simoes EA. Respiratory syncytial virus infection. Lancet 1999;354:847-52.
16. Simoes 2003 Simoes EA, Carbonell-Estrany X. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Pediatric Infectious Disease Journal 2003;22(Suppl):13- 8.
17. Yount 2004 Yount LE, Mahle MT. Economic analysis of Palivizumab in infants with congenital heart disease. Pediatrics 2004;114:1606- 11.
18. Wang 1999 Wang EEL, Tang NK. Immunoglobulin for preventing respiratory syncytial virus infection. Cochrane Database of Systematic Reviews 1999, Issue 3.Art. No.: CD001725. DOI: 10.1002/14651858.CD001725. pub2.